Dcf Advisers, LLC Sangamo Therapeutics, Inc Transaction History

Dcf Advisers, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$9.01 - $12.01 $118,031 - $157,331	-13,100 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$10.17 - $12.64 $9,153 - $11,376	-900 Reduced 6.43%	13,100 $157,000
Q4 2020 Feb 12, 2021	SELL	$9.23 - $18.18 $243,672 - $479,952	-26,400 Reduced 65.35%	14,000 $218,000
Q3 2020 Nov 13, 2020	SELL	$9.38 - $12.48 $281,400 - $374,400	-30,000 Reduced 42.61%	40,400 $382,000
Q2 2020 Aug 13, 2020	BUY	$6.21 - $11.83 $102,465 - $195,195	16,500 Added 30.61%	70,400 $631,000
Q4 2019 Feb 12, 2020	BUY	$8.03 - $11.7 $432,816 - $630,630	53,900 New	53,900 $451,000

111

56.7M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Dcf Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Dcf Advisers, LLC with notifications on news.